April 18, 2011
A New York federal judge on Thursday tossed out American Sales Co. Inc.'s proposed class action alleging AstraZeneca AB and The Procter & Gamble Co. initiated sham patent suits in order to perpetuate an unlawful monopoly over Prilosec OTC.